NPR’s Michel Martin speaks with Harvard Medical School’s Ameet Sarpatwari about the legal battle over mifepristone and how it might affect the drug market in the U.S. and beyond.
NPR’s Michel Martin speaks with Harvard Medical School’s Ameet Sarpatwari about the legal battle over mifepristone and how it might affect the drug market in the U.S. and beyond.